Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/167785
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. Here, we describe a set of protein-combination panels in urinary extracellular vesicles (EVs), defined by targeted proteomics and immunoblotting techniques that improve early non-invasive detection and stratification of PCa patients.We report a two-protein combination in urinary EVs that classifies benign and PCa patients (ADSV-TGM4), and a combination of five proteins able to significantly distinguish between high- and low-grade PCa patients (CD63-GLPK5-SPHM-PSA-PAPP). Proteins composing the panels were validated by immunohistochemistry assays in tissue microarrays (TMAs) confirming a strong link between the urinary EVs proteome and alterations in PCa tissues. Moreover, ADSV and TGM4 abundance yielded a high diagnostic potential in tissue and promising TGM4 prognostic power. These results suggest that the proteins identified in urinary EVs distinguishing high- and low grade PCa are a reflection of histological changes that may be a consequence of their functional involvement in PCa development. In conclusion, our study resulted in the identification of protein-combination panels present in urinary EVs that exhibit high sensitivity and specificity for PCa detection and patient stratification. Moreover, our study highlights the potential of targeted proteomic approaches-such as selected reaction monitoring (SRM)-as diagnostic assay for liquid biopsies via urinary EVs to improve diagnosis and prognosis of suspected PCa patients.
Matèries
Matèries (anglès)
Citació
Citació
SEQUEIROS, Tamara, RIGAU, Marina, CHIVA, Cristina, MONTES, Melania, GARCIA-GRAU, Iolanda, GARCIA, Marta, DIAZ, Sherley, CELMA, Ana, BIJNSDORP, Irene, CAMPOS, Alex, MAURO, Primiano di, BORRÓS, Salvador, REVENTÓS PUIGJANER, Jaume, DOLL, Andreas, PACIUCCI BARZANTI, Rosanna, PEGTEL, D. michiel, TORRES, Inés de, SABIDÓ AGUADÉ, Eduard, MOROTE, Juan, OLIVAN RIERA, Mireia. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. _Oncotarget_. 2017. Vol. 8, núm. 3, pàgs. 4960-4976. [consulta: 24 de gener de 2026]. ISSN: 1949-2553. [Disponible a: https://hdl.handle.net/2445/167785]